INS and type 2 diabetes mellitus: The current pathogenic paradigm for T2D maintains that glycemic control reflects the interplay between insulin availability and the sensitivity / resistance to insulin of the main tissues engaged in carbo-lipid metabolism, namely, liver, muscle and adipose tissue.